-+ 0.00%
-+ 0.00%
-+ 0.00%

Keros Therapeutics Director Charles W. Newton Reports Sale of 551 Common Shares for $5,980.53

PUBT·11/19/2026 21:10:56
Listen to the news
Keros Therapeutics Director Charles W. Newton Reports Sale of 551 Common Shares for $5,980.53
  • Keros Therapeutics director Charles W. Newton sold 551 common shares on November 17, 2026.
  • Sales comprised 491 shares at $10.83 per share; another 60 shares sold at $11.05 per share.
  • His direct beneficial ownership fell to 11,563 common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001866219-26-000012), on November 19, 2026, and is solely responsible for the information contained therein.